Startups

SCENT S.r.l (SemiConductor-based Electronic Network for Tumors) is a company whose mission is to design, test, manufacture and market screening tools for detection of tumor formations and pathologies through the analysis of chemical variations in the composition of the gases produced by human organism.

Cellply is a biotechnology company that develops scientific tools automating cell-based functional assays whose aim is to deeply characterize the mode of action of both approved and novel anti-cancer drugs, being able to evaluate the heterogeneity in function of both immune and tumor cells with a single-cell resolution.